Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) Shares Outstanding (Weighted Average) (2016 - 2026)

Integra Lifesciences Holdings' Shares Outstanding (Weighted Average) history spans 17 years, with the latest figure at $76.7 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) changed 0.44% to $76.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $76.7 million, a 0.44% change, with the full-year FY2025 number at $76.7 million, changed 0.44% from a year prior.
  • Shares Outstanding (Weighted Average) hit $76.7 million in Q4 2025 for Integra Lifesciences Holdings, roughly flat from $76.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for IART hit a ceiling of $84.8 million in Q3 2021 and a floor of $76.5 million in Q1 2025.
  • Historically, Shares Outstanding (Weighted Average) has averaged $80.5 million across 5 years, with a median of $80.8 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 0.51% in 2021 and later dropped 5.05% in 2024.
  • Tracing IART's Shares Outstanding (Weighted Average) over 5 years: stood at $84.7 million in 2021, then dropped by 2.01% to $83.0 million in 2022, then fell by 3.5% to $80.1 million in 2023, then decreased by 3.84% to $77.0 million in 2024, then dropped by 0.44% to $76.7 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for IART at $76.7 million in Q4 2025, $76.8 million in Q3 2025, and $76.7 million in Q2 2025.